REGN vs ABBV
Regeneron Pharmaceuticals vs AbbVie — AI-powered side-by-side comparison
| Metric | REGN | ABBV |
|---|---|---|
| AI Score | 65 | 54 |
| Price | $664.56 | $247.97 |
| P/E Ratio | 15.80× | 121.64× |
| ROE | 14.3% | -1.3% |
| Revenue Growth YoY | 5.9% | — |
| Gross Margin | 85.7% | 0.7% |
| Debt / Equity | 0.09× | 2.65× |
| Dividend Yield | 0.6% | 0.0% |
| RSI (14) | 65.3 | 53.2 |
| Beta | 0.2076 | 0.283 |
| Expected Upside | +12.5% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
REGN Full Analysis
ABBV Full Analysis